Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Alejandro Vanegas"'
Autor:
Cristian Marcelo Sotomayor-Bustos, Martín Javier Durán-Hermida, Alejandro Vanegas-Ramos, Daniela Idrovo-Alvarado, Manuela Cordero-Salcedo, Jonnatan Avilés-González, Ana Rodas-Beltrán
Publikováno v:
Daya, Vol 14, Iss Junio 2023 - Noviembre 2023, Pp 105-122 (2023)
La expansión urbana es un fenómeno recurrente hoy en día en ciudades latinoamericanas intermedias. En Cuenca, Ecuador, la mayoría de los planes de vivienda de interés público que se construyen actualmente, se desarrollan en la periferia urbana,
Externí odkaz:
https://doaj.org/article/29f5f1e312b641c29ea2830e7e89d03a
Autor:
Shailender Bhatia, Paul Nghiem, Alejandro Vanegas, Kristina Lachance, Lisa Tachiki, Kevin Chiu, Emily Boller, Murtuza Bharmal, S Phani Veeranki
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 8 (2022)
Background Merkel cell carcinoma (MCC) is a rare, aggressive, cutaneous neuroendocrine neoplasm with annual incidence rates of 0.13–1.6 cases/100,000/year worldwide as of 2018. Chemotherapy for metastatic MCC (mMCC) has high objective response rate
Externí odkaz:
https://doaj.org/article/d79eda3aab224e61afca0b4ea644373c
Autor:
Shailender Bhatia, Paul Nghiem, S Phani Veeranki, Alejandro Vanegas, Kristina Lachance, Lisa Tachiki, Kevin Chiu, Emily Boller, Murtuza Bharmal
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/2ca86f725a6f4754825e4ba57fcc15c2
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background Breast cancer chemoprevention can reduce breast cancer incidence in high-risk women; however, chemoprevention is underutilized in the primary care setting. We conducted a pilot study of decision support tools among high-risk women
Externí odkaz:
https://doaj.org/article/4c2ce2db64d2410ea8fb7e3e000e7335
Autor:
Katherine D. Crew, Thomas B. Silverman, Alejandro Vanegas, Meghna S. Trivedi, Jill Dimond, Jennie Mata, Margaret Sin, Tarsha Jones, Mary Beth Terry, Wei-Yann Tsai, Rita Kukafka
Publikováno v:
Contemporary Clinical Trials Communications, Vol 16, Iss , Pp - (2019)
Background: Chemoprevention using selective estrogen receptor modulators and aromatase inhibitors has been shown to reduce invasive breast cancer incidence in high-risk women. Despite this evidence, few high-risk women who are eligible for chemopreve
Externí odkaz:
https://doaj.org/article/4b15d18f76774134b14f1b733653ded8
Autor:
Thomas B. Silverman, Alejandro Vanegas, Awilda Marte, Jennie Mata, Margaret Sin, Juan Carlos Rodriguez Ramirez, Wei-Yann Tsai, Katherine D. Crew, Rita Kukafka
Publikováno v:
BMC Health Services Research, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background BRCA1 and BRCA2 mutations confer a substantial breast risk of developing breast cancer to those who carry them. For this reason, the United States Preventative Services Task Force (USPSTF) has recommended that all women be screene
Externí odkaz:
https://doaj.org/article/8c39046d7c9a4ac38226b8a17474d9b6
Publikováno v:
ARQ, Iss 71, Pp 38-41 (2009)
La superposición de usos en un barrio en una ladera de la ciudad de Cuenca da lugar a un pequeño edificio que acoge viviendas, oficinas y un restaurante en 50 m de largo y 12 m de desnivel. La pendiente determina espacios interiores y exteriores en
Externí odkaz:
https://doaj.org/article/598f829b30604b62ab880dddc8fe0a84
Autor:
Katherine D. Crew, Rita Kukafka, Rossy Sandoval, Jennifer Vargas, Alejandro Vanegas, Raven David, Hae Seung Yi, Meghna S. Trivedi, William Ueng, Julia E. McGuinness
Baseline characteristics of the Know Your Risk: Assessment at Screening (KYRAS) study sample (N=2019) compared to the remaining screened cohort not enrolled in the KYRAS study, New York, NY (November 2014-October 2015)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6fb6fd2a0d04d8e1c441234304ea302
https://doi.org/10.1158/1055-9965.22438231.v1
https://doi.org/10.1158/1055-9965.22438231.v1
Autor:
Katherine D. Crew, Rita Kukafka, Rossy Sandoval, Jennifer Vargas, Alejandro Vanegas, Raven David, Hae Seung Yi, Meghna S. Trivedi, William Ueng, Julia E. McGuinness
Background: Potential harms of screening mammography include false positive results, such as recall breast imaging or biopsies.Methods: We recruited women undergoing screening mammography at Columbia University Medical Center in New York, New York. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9beb137e48b3c7a03d007021079aa675
https://doi.org/10.1158/1055-9965.c.6516277.v1
https://doi.org/10.1158/1055-9965.c.6516277.v1
Autor:
Paul Nghiem, Lisa Tachiki, Emily Boller, Shailender Bhatia, K. Lachance, Murtuza Bharmal, Alejandro Vanegas, Kevin Chiu, S Phani Veeranki
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundMerkel cell carcinoma (MCC) is a rare, aggressive cutaneous neuroendocrine neoplasm with annual incidence rates ranging from 0.13 to 1.6 cases per 100,000 per year.1 Chemotherapy for metastatic MCC (mMCC) has high objective response rates (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10c20647f84cc6bc9b3c573876d45a62
https://doaj.org/article/2ca86f725a6f4754825e4ba57fcc15c2
https://doaj.org/article/2ca86f725a6f4754825e4ba57fcc15c2